U.S. Markets closed

Analysts Reduce Target Price for Bausch Health Companies in March

Margaret Patrick
Analysts Reduce Target Price for Bausch Health Companies in March

What Analysts Think about These Generic Pharmaceutical StocksAnalysts’ recommendations and target price Wall Street analysts expect an upside potential of 24.28% for Bausch Health Companies (BHC) based on the company’s closing price on March 22.